People who catch COVID-19 have at least a one in four chance of developing long-haul COVID with symptoms lasting months, even if they have very mild cases, are young and are in excellent health, new studies show.
Jersey Mike’s restaurant’s 11th annual ‘Day of Giving’ caps off month-long fundraiser for charity. Local franchisees to give all proceeds to help kids treated at UC Davis Children’s Hospital.
The Sacramento Business Journal has named UC Davis Chancellor Gary S. May and Vice Chancellor of Human Health Sciences and UC Davis Health CEO David Lubarsky to its list of the Sacramento area’s Most Admired CEOs.
UC Davis Health earned The Joint Commission’s Gold Seal of Approval™ for its Ventricular Assist Device Program. It is part of the Comprehensive Heart Failure Program, which delivers state-of-the-art care for patients with advanced heart failure.
Scientists at UC San Francisco, UC Berkeley and UCLA have received U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patient’s own blood-forming stem cells.
UC San Diego alumni make a gift of $1 million towards first-of-its-kind pediatric research. The Cathy and Richard Tryon Pediatric Facial/Psychological Trauma Research Fund will support research at UC San Diego to benefit pediatric patients who have suffered from traumatic facial deformities.
More than a year ago, 14-year-old Aija Hall and her mother Angela Lasseter received the devastating news that she had focal segmental glomerulosclerosis (FSGS), a disease in which scar tissue develops on the parts of the kidneys that filter waste from the blood.
